China Dry Age Related Macular Degeneration Market

ID: MRFR/MED/43221-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026
China Dry Age-Related Macular Degeneration (AMD) Market Research Report: Size, Share, Trend Analysis By Stage (Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration), By Age Group (Above 75 years, Above 60 years, Above 40 years), By Diagnosis and Treatment (Treatment, Diagnosis), By Route of Administration (Oral, Injectables) and By End Userss (Hospitals Clinics, Diagnostic Centers, Academic Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035
China Dry Age Related Macular Degeneration Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.52%
2024 Market Size$ 357 Million
2025 Market Size$ 386.62 Million
2035 Market Size$ 792.75 Million
Key Players
Novartis
Roche
Regeneron Pharmaceuticals
Bayer
Allergan
Santen Pharmaceutical
Trends
  • Rising Prevalence of Dry AMD
  • Government Initiatives and Support
  • Technological Advancements in Treatment
Opportunities
  • Rising Prevalence of Dry AMD
  • Rising Awareness and Education
  • Increasing Healthcare Expenditure
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Clinical Diagnosis
      2. 4.1.2 Research and Development
      3. 4.1.3 Patient Monitoring
      4. 4.1.4 Therapeutic Intervention
    2. 4.2 Healthcare, BY End User (USD Million)
      1. 4.2.1 Hospitals
      2. 4.2.2 Ophthalmology Clinics
      3. 4.2.3 Research Institutions
      4. 4.2.4 Home Care Settings
    3. 4.3 Healthcare, BY Product Type (USD Million)
      1. 4.3.1 Diagnostic Devices
      2. 4.3.2 Therapeutic Devices
      3. 4.3.3 Monitoring Devices
      4. 4.3.4 Surgical Instruments
    4. 4.4 Healthcare, BY Technology (USD Million)
      1. 4.4.1 Optical Coherence Tomography
      2. 4.4.2 Fundus Photography
      3. 4.4.3 Fluorescein Angiography
      4. 4.4.4 Laser Treatment
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Novartis (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Regeneron Pharmaceuticals (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Bayer (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Allergan (IE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Santen Pharmaceutical (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Hua Medicine (CN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Chongqing Zhifei Biological Products (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
    3. 6.3 CHINA MARKET ANALYSIS BY END USER
    4. 6.4 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    5. 6.5 CHINA MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 HEALTHCARE, BY END USER, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY END USER, 2026-2035 (USD Million)
      3. 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
      4. 7.2.4 BY TECHNOLOGY, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Dry Age Related Macular Degeneration Market Segmentation

China Dry Age Related Macular Degeneration Market By Application (USD Million, 2026-2035)

  • Clinical Diagnosis
  • Research and Development
  • Patient Monitoring
  • Therapeutic Intervention

China Dry Age Related Macular Degeneration Market By End User (USD Million, 2026-2035)

  • Hospitals
  • Ophthalmology Clinics
  • Research Institutions
  • Home Care Settings

China Dry Age Related Macular Degeneration Market By Product Type (USD Million, 2026-2035)

  • Diagnostic Devices
  • Therapeutic Devices
  • Monitoring Devices
  • Surgical Instruments

China Dry Age Related Macular Degeneration Market By China Dry Age Related Macular Degeneration Market (USD Million, 2026-2035)

  • Optical Coherence Tomography
  • Fundus Photography
  • Fluorescein Angiography
  • Laser Treatment

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.